Behavior of platinum(iv) complexes in models of tumor hypoxia: Cytotoxicity, compound distribution and accumulation

Metallomics

Volumn 8, Issue 4, 2016, Pages 422-433

  Schreiber Brynzak, Ekaterina ^a   Pichler, Verena ^a   Heffeter, Petra ^a,b   Hanson, Buck ^a   Theiner, Sarah ^a   Lichtscheidl Schultz, Irene ^a   Kornauth, Christoph ^c   Bamonti, Luca ^a   Dhery, Vineet ^a,b   Groza, Diana ^a,b   Berry, David ^a   Berger, Walter ^a,b   Galanski, Markus ^a   Jakupec, Michael A ^a   Keppler, Bernhard K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CYTOTOXICITY; DIAGNOSIS; DISEASES; TUMORS;

ANTI-TUMOR ACTIVITIES; CANCER THERAPEUTICS; COMPOUND DISTRIBUTIONS; CONVENTIONAL METALS; MONOLAYER CULTURE; MULTICELLULAR SPHEROID; RATE OF REDUCTION; TWO-STEP SCREENING;

PLATINUM COMPOUNDS;

PLATINUM COMPLEX; PRODRUG; SATRAPLATIN; COORDINATION COMPOUND; PLATINUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOTRANSFORMATION; CANCER CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVATION; HUMAN; HUMAN CELL; HYPOXIA; LIPOPHILICITY; MALE; METASTASIS; MONOLAYER CULTURE; MOUSE; MULTICELLULAR SPHEROID; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCREENING; SOLID TUMOR; XENOGRAFT; ANIMAL; BIOLOGICAL MODEL; CELL DEATH; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; MASS SPECTROMETRY; PATHOLOGY; SCID MOUSE; TISSUE DISTRIBUTION; TUMOR CELL LINE; TUMOR HYPOXIA;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; COORDINATION COMPLEXES; HUMANS; MALE; MASS SPECTROMETRY; MICE, SCID; MODELS, BIOLOGICAL; PLATINUM; SPHEROIDS, CELLULAR; TISSUE DISTRIBUTION; TUMOR HYPOXIA;

EID: 84969530902     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c5mt00312a     Document Type: Article

References (41)

1. L. Kelland Nat. Rev. Cancer 2007 7 8 573 584
2. X. Yao K. Panichpisal N. Kurtzman K. Nugent Am. J. Med. Sci. 2007 334 2 115 124
3. M. H. Hanigan P. Devarajan Cancer Ther. 2003 1 47 61
4. H. Choy Expert Rev. Anticancer Ther. 2006 6 7 973 982
5. H. Choy C. Park M. Yao Clin. Cancer Res. 2008 14 6 1633 1638
6. J. W. Smith 2nd K. J. McIntyre P. V. Acevedo C. A. Encarnacion K. L. Tedesco Y. Wang L. Asmar J. A. O'Shaughnessy Breast Cancer Res. Treat. 2009 118 2 361 367
7. R. W. Gregg J. M. Molepo V. J. Monpetit N. Z. Mikael D. Redmond M. Gadia D. J. Stewart J. Clin. Oncol. 1992 5 795 803
8. M. D. Galsky L. H. Camacho E. G. Chiorean D. Mulkerin D. S. Hong W. K. Oh D. F. Bajorin Ann. Oncol. 2012 23 4 1037 1044
9. G. Doshi G. Sonpavde C. N. Sternberg Expert Opin. Drug Metab. Toxicol. 2012 8 1 103 111
10. M. D. Galsky S. Seng L. H. Camacho E. G. Chiorean D. Mulkerin D. S. Hong W. K. Oh D. F. Bajorin Clin. Genitourin. Cancer 2011 9 1 27 30
11. E. Wexselblatt D. Gibson J. Inorg. Biochem. 2012 117 220 229
12. S. Vouillamoz-Lorenz T. Buclin F. Lejeune J. Bauer S. Leyvraz L. A. Decosterd Anticancer Res. 2003 23 3C 2757 2765
13. L. H. Gray A. D. Conger M. Ebert S. Hornsey O. C. Scott Br. J. Radiol. 1953 26 638 648
14. Radiobiology for the radiologist, ed., E. J. Hall, Lippincott, Philadelphia PA, 4th edn, 1994
15. R. P. Hill, The basic science of oncology, 1992, pp. 259-275
16. T. G. Graeber C. Osmanian T. Jacks D. E. Housman C. J. Koch S. W. Lowe et al. Nature 1996 379 88 91
17. C. Y. Kim M. H. Tsai C. Osmanian T. G. Graeber J. E. Lee R. G. Giffard et al. Cancer Res. 1997 57 4200 4204
18. R. E. Durand P. L. Olive Methods Cell Biol. 2001 64 211 233
19. A. M. Shannon D. J. Bouchier-Hayes C. M. Condron D. Toomey Cancer Treat. Rev. 2003 29 4 297 307
20. G. Helmlinger F. Yuan M. Dellian R. K. Jain Nat. Med. 1997 3 177 182
21. M. D. Hall H. R. Mellor R. Callaghan T. W. Hambley J. Med. Chem. 2007 50 15 3403 3411
22. N. Graf J. Stephen Adv. Drug Delivery Rev. 2012 64 11 993 1004
23. H. R. Mellor S. Snelling M. D. Hall S. Modok M. Jaffar T. W. Hambley R. Callaghan Biochem. Pharmacol. 2005 70 8 1137 1146
24. V. Pichler S. Göschl E. Schreiber-Brynzak M. A. Jakupec M. Galanski B. K. Keppler Metallomics 2015 7 1078 1090
25. E. Schreiber-Brynzak E. Klapproth C. Unger I. Lichtscheidl-Schultz S. Göschl S. Schweighofer R. Trondl H. Dolznig M. A. Jakupec B. K. Keppler Invest. New Drugs 2015 33 4 835 847
26. W. F. Mueller-Klieser R. M. Sutherland Br. J. Cancer 1982 45 2 256 264
27. H. Acker J. Carlsson W. Mueller-Klieser R. M. Sutherland Br. J. Cancer 1987 56 3 325 327
28. J. Chiche M. C. Brahimi-Horn J. Pouysségur J. Cell. Mol. Med. 2010 14 4 771 794
29. L. E. Gerweck K. Seetharaman Cancer Res. 1996 56 6 1194 1198
30. A. Görlach H. Acker Molecular Basis of Disease 1994 1227 3 105 112
31. J. Jiang C. Auchinvole K. Fisher C. J. Campbell Nanoscale 2014 6 12104 12110
32. R. J. Knox F. Friedlos D. A. Lydall J. J. Roberts Cancer Res. 1986 46 4 Pt 2 1972 1979
33. T. Zimmerman J. Leszczynski J. V. Burda J. Mol. Model. 2011 17 9 2385 2393
34. S. Walenta J. Doetsch W. Mueller-Klieser L. A. Kunz-Schughart J. Histochem. Cytochem. 2000 48 509 522
35. C. Mischiati B. Ura L. Roncoroni L. Elli C. Cervellati M. Squerzanti D. Conte L. Doneda P. Polverino de Laureto G. de Franceschi R. Calza C. A. Barrero S. Merali C. Ferrari C. M. Bergamini E. Agostinelli PLoS One 2015 10 3 e0118906
36. D. J. Kerr T. E. Wheldon S. Hydns S. B. Kaye Xenobiotica 1988 18 6 641 648
37. G. Mehta A. Y. Hsiao M. Ingram G. D. Luker S. Takayama J. Controlled Release 2012 164 2 192 204
38. V. Pichler S. Göschl S. M. Meier A. Roller M. A. Jakupec M. Galanski B. K. Keppler Inorg. Chem. 2013 52 8151 8162
39. S. Theiner C. Kornauth H. P. Varbanov M. Galanski S. Van Schoonhoven P. Heffeter W. Berger A. E. Egger B. K. Keppler Metallomics 2015 7 1256 1264
40. C. Korch M. A. Spillman T. A. Jackson B. M. Jacobsen S. K. Murphy B. A. Lessey V. C. Jordan A. P. Bradford Gynecol. Oncol. 2012 127 241 248
41. C. Paton J. Hellstrom B. Paul J. Woodhead J. Hergt J. Anal. At. Spectrom. 2011 26 2508 2518